Oculis
Jonathan Barber serves as the Vice President and Head of Global Regulatory Affairs at Oculis since July 2024, overseeing the strategic execution of regulatory affairs activities and medical writing. Previously, Barber held the role of Vice President of Regulatory Affairs at ERYTECH Pharma, leading North American regulatory activities for advanced therapy medicinal products from July 2021 to June 2024. Additional experience includes serving as Global Head of Regulatory Affairs-CMC and MSAT at ERYTECH Pharma, and various leadership positions at Kyowa Kirin, Inc., Valeant Pharmaceuticals, and Bristol-Myers Squibb, focusing on regulatory CMC submission strategies and compliance for biologics and small molecules. Jonathan Barber holds a Bachelor's degree in Biology from Rutgers University and is pursuing further studies in Analytical Chemistry at Seton Hall University, complemented by a Master's in Science from Temple University.
This person is not in any teams
This person is not in any offices
Oculis
1 followers
Oculis is a clinical stage biopharmaceutical company whose mission is to develop novel topical treatments (eye drops) for ophthalmic diseases for both back-and front-of-the-eye in order to improve the sight and the lives of patients worldwide.